{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.248G>A",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "A",
            "position": "248"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "83"
          },
          "Description in input context": "c.248G>A (p.G83D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005255"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using the HEK293 cell line."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.248G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression was reduced by 50% for the variant NM_000345.3:c.248G>A."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80% on day 7.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50% on day 7.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Fibroblasts from PD patients",
        "Description": "Immunofluorescence was performed on fibroblasts derived from PD patients."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.248G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "α-synuclein aggregation increased by 60% in fibroblasts with the variant NM_000345.3:c.248G>A."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type fibroblasts were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Fibroblasts from healthy controls were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Aggregation <50% in healthy controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Aggregation >30% in PD fibroblasts.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Behavioral Assay",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Drosophila melanogaster",
        "Description": "Behavioral assays were conducted on Drosophila melanogaster expressing the variant."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.248G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Locomotor activity decreased by 40% in Drosophila expressing the variant NM_000345.3:c.248G>A."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type flies were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Flies overexpressing wild-type α-synuclein were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Kruskal-Wallis test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Locomotor activity >60% in wild-type flies.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Locomotor activity <40% in variant-expressing flies.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}